Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH; Southwest Oncology Group, Head and Neck Working Group. Worden FP, et al. Among authors: ensley j. Cancer. 2006 Jul 15;107(2):319-27. doi: 10.1002/cncr.21994. Cancer. 2006. PMID: 16779801 Free article. Clinical Trial.
Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study.
Samlowski WE, Moon J, Kuebler JP, Nichols CR, Gandara DR, Ozer H, Williamson SK, Atkins JN, Schuller DE, Ensley JF. Samlowski WE, et al. Among authors: ensley jf. Cancer Invest. 2007 Apr-May;25(3):182-8. doi: 10.1080/07357900701209061. Cancer Invest. 2007. PMID: 17530488 Clinical Trial.
Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
Hussain M, Benedetti J, Smith RE, Rodriguez GI, Schuller D, Ensley J. Hussain M, et al. Among authors: ensley j. Cancer. 1995 Oct 1;76(7):1233-7. doi: 10.1002/1097-0142(19951001)76:7<1233::aid-cncr2820760721>3.0.co;2-q. Cancer. 1995. PMID: 8630903 Clinical Trial.
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA; Eastern Cooperative Oncology Group. Gibson MK, et al. Among authors: ensley j. J Clin Oncol. 2005 May 20;23(15):3562-7. doi: 10.1200/JCO.2005.01.057. J Clin Oncol. 2005. PMID: 15908667 Clinical Trial.
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK, et al. Forastiere AA, et al. Among authors: ensley jf. J Clin Oncol. 1992 Aug;10(8):1245-51. doi: 10.1200/JCO.1992.10.8.1245. J Clin Oncol. 1992. PMID: 1634913 Clinical Trial.
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G. Yoo GH, et al. Among authors: ensley j. Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):869-74. doi: 10.1001/archoto.2009.122. Arch Otolaryngol Head Neck Surg. 2009. PMID: 19770418 Free PMC article. Clinical Trial.
123 results